ID   26/27
AC   CVCL_E439
SY   02627
DR   dbMHC; 48457
DR   ECACC; 94022517
DR   IHW; IHW09251
DR   IPD-IMGT/HLA; 10114
DR   Wikidata; Q54583672
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Native Central American; Pima.
CC   HLA typing: A*02:01,24:02; B*51:02:01,48:01:01; C*08:01:01; DPB1*02:01:02,04:02; DQB1*03; DRB1*14; DRB3*01 (IPD-IMGT/HLA=10114).
CC   HLA typing: A*02:01:01:01,24:02:01:01; B*48:01:01,51:02:01; C*08:01:01; DPA1*01:03:01:01,01:03:01:05; DPB1*02:01:02(416:01),04:02:01:02(105:01); DQA1*05:03; DQB1*03:01:01:01; DRB1*14:02:01; DRB3*01:01:02 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
RX   PubMed=30844424; DOI=10.1016/j.humimm.2019.03.001;
RA   Creary L.E., Guerra S.G., Chong W., Brown C.J., Turner T.R.,
RA   Robinson J., Bultitude W.P., Mayor N.P., Marsh S.G.E., Saito K.,
RA   Lam K., Duke J.L., Mosbruger T.L., Ferriola D., Monos D.S., Willis A.,
RA   Askar M., Fischer G.F., Saw C.L., Ragoussis J., Petrek M.,
RA   Serra-Pages C., Juan Otero M., Stavropoulos-Giokas C., Dinou A., Ameen R.,
RA   Al Shemmari S., Spierings E., Gendzekhadze K., Morris G.P., Zhang Q.-H.,
RA   Kashi Z., Hsu S., Gangavarapu S., Mallempati K.C., Yamamoto F.,
RA   Osoegawa K., Vayntrub T., Chang C.-J., Hansen J.A.,
RA   Fernandez-Vina M.A.;
RT   "Next-generation HLA typing of 382 International Histocompatibility
RT   Working Group reference B-lymphoblastoid cell lines: report from the
RT   17th International HLA and Immunogenetics Workshop.";
RL   Hum. Immunol. 80:449-460(2019).
//